Are There Any Challenges in Implementing Nanotechnology in Cardiovascular Imaging?
While nanotechnology holds great promise, there are challenges to be addressed:
Biocompatibility: Ensuring that nanoparticles do not induce adverse immune responses or toxicity is crucial. Regulatory Approval: The approval process for new nanomaterials can be lengthy and stringent, requiring extensive testing for safety and efficacy. Cost: The development and production of nanoparticles can be expensive, which may limit their widespread adoption. Scalability: Manufacturing nanoparticles consistently and at scale remains a significant hurdle.
